These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8433568)

  • 1. Molecular genetics of Alport syndrome.
    Tryggvason K; Zhou J; Hostikka SL; Shows TB
    Kidney Int; 1993 Jan; 43(1):38-44. PubMed ID: 8433568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutations in the COL4A5 collagen gene in Alport syndrome.
    Barker DF; Hostikka SL; Zhou J; Chow LT; Oliphant AR; Gerken SC; Gregory MC; Skolnick MH; Atkin CL; Tryggvason K
    Science; 1990 Jun; 248(4960):1224-7. PubMed ID: 2349482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aspects of Alport's syndrome.
    Weber M; Netzer KO; Pullig O
    Clin Investig; 1992 Sep; 70(9):809-15. PubMed ID: 1450636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome: from bedside to genome to bedside.
    Kashtan CE; Michael AF
    Am J Kidney Dis; 1993 Nov; 22(5):627-40. PubMed ID: 8238007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).
    Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP
    Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.
    Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M
    J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome.
    Knebelmann B; Breillat C; Forestier L; Arrondel C; Jacassier D; Giatras I; Drouot L; Deschênes G; Grünfeld JP; Broyer M; Gubler MC; Antignac C
    Am J Hum Genet; 1996 Dec; 59(6):1221-32. PubMed ID: 8940267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alport syndrome. A review of the ocular manifestations.
    Colville DJ; Savige J
    Ophthalmic Genet; 1997 Dec; 18(4):161-73. PubMed ID: 9457747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; Weber M; Netzer KO; Sun MJ; Neilson EG; Hudson BG
    Kidney Int; 1994 Mar; 45(3):721-6. PubMed ID: 8196274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
    Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
    Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of alpha 5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus.
    Myers JC; Jones TA; Pohjolainen ER; Kadri AS; Goddard AD; Sheer D; Solomon E; Pihlajaniemi T
    Am J Hum Genet; 1990 Jun; 46(6):1024-33. PubMed ID: 2339699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COL4A5 splice site mutation and alpha 5(IV) collagen mRNA in Alport syndrome.
    Netzer KO; Pullig O; Frei U; Zhou J; Tryggvason K; Weber M
    Kidney Int; 1993 Feb; 43(2):486-92. PubMed ID: 8441246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.